Signal1bb186dc

WEBINDEXED

Pfizer Phase 3 trial protocol document reveals 44% efficacy vs. infection (not hospitalization), omitted in FDA-approved Comirnaty label summaries by media.

Author:phmpt.org

Published:2021-11-01 00:00 UTC

Occurred:2020-12-01 00:00 UTC

Received:2026-04-17 08:05 UTC

Status Score

91%

ITG

99%

IMP

96%

NAR

88%

Analysis Insights

Topics Detected

#Vaccines#Clinical Trials

Entities Mentioned

@Pfizer

Technical Details

Analyst Mission

Media Bias Detector774af710...

Source IDN/A

Original URLhttps://www.phmpt.org/wp-content/uploads/2021/11/Reissue_125742_S1_M5_c459foi-4229-83817414.pdf

Database ID1bb186dc-088d-446f-9e1d-9ab81a143b3c

Raw Data

{
  "id": "1bb186dc-088d-446f-9e1d-9ab81a143b3c",
  "content": "Pfizer Phase 3 trial protocol document reveals 44% efficacy vs. infection (not hospitalization), omitted in FDA-approved Comirnaty label summaries by media.",
  "url": "https://www.phmpt.org/wp-content/uploads/2021/11/Reissue_125742_S1_M5_c459foi-4229-83817414.pdf",
  "source_type": "web",
  "source_id": null,
  "author_id": "phmpt.org",
  "published_at": "2021-11-01T00:00:00.000Z",
  "received_at": "2026-04-17T08:05:02.133Z",
  "status": "indexed",
  "relevance_score": 91,
  "case_id": null,
  "metadata": {
    "topics": [
      "Vaccines",
      "Clinical Trials"
    ],
    "mission": "Media Bias Detector",
    "mentions": [
      "Pfizer"
    ],
    "mission_id": "774af710-3ec0-41fe-8957-eb9ca43360ee"
  },
  "credibility_score": 99,
  "actionability_score": 96,
  "emotional_score": 88,
  "occurred_at": "2020-12-01T00:00:00.000Z",
  "case_ids": null
}